Use of Inhaled and Oral Corticosteroids and the Long-term Risk of Cataract

Ophthalmology

Volumn 116, Issue 4, 2009, Pages 652-657

  Wang, Jie Jin ^a,b   Rochtchina, Elena ^a   Tan, Ava Grace ^a   Cumming, Robert G ^c   Leeder, Stephen R ^d   Mitchell, Paul ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID DERIVATIVE; CORTISONE; DEXAMETHASONE; PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CATARACT; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; EDUCATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NUCLEAR CATARACT; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SUBCAPSULAR CATARACT; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ARTHRITIS; ASTHMA; CATARACT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INCIDENCE; LENS CAPSULE, CRYSTALLINE; MALE; MIDDLE AGED; NEW SOUTH WALES; PHOTOGRAPHY; QUESTIONNAIRES; RISK FACTORS;

EID: 63149120447     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.001     Document Type: Article

References (34)

1. Frew A.J., and Plummeridge M.J. Alternative agents in asthma. J Allergy Clin Immunol 108 (2001) 3-10
2. Cumming R.G., Mitchell P., and Leeder S.R. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 337 (1997) 8-14
3. Chylack Jr. L.T. Cataracts and inhaled corticosteroids. N Engl J Med 337 (1997) 46-48
4. Garbe E., Suissa S., and LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 280 (1998) 539-543
5. Ernst P., Baltzan M., Deschenes J., and Suissa S. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 27 (2006) 1168-1174
6. Hodge W.G., Whitcher J.P., and Satariano W. Risk factors for age-related cataracts. Epidemiol Rev 17 (1995) 336-346
7. Black R.L., Oglesby R.B., Von Sallmann L., and Bunim J.J. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 174 (1960) 166-171
8. Derby L., and Maier W.C. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol 105 (2000) 912-916
9. Toogood J.H., Markov A.E., Baskerville J., and Dyson C. Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. J Allergy Clin Immunol 91 (1993) 571-579
10. Cave A., Arlett P., and Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 83 (1999) 153-179
11. Uboweja A., Malhotra S., and Pandhi P. Effect of inhaled corticosteroids on risk of development of cataract: a meta-analysis. Fundam Clin Pharmacol 20 (2006) 305-309
12. Gartlehner G., Hansen R.A., Carson S.S., and Lohr K.N. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med 4 (2006) 253-262
13. Smeeth L., Boulis M., Hubbard R., and Fletcher A.E. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol 87 (2003) 1247-1251
14. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med 100 (2006) 1307-1317
15. Allen D.B., Bielory L., Derendorf H., et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 112 suppl (2003) S1-S40
16. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
17. Mitchell P., Cumming R.G., Attebo K., and Panchapakesan J. Prevalence of cataract in Australia: the Blue Mountains Eye Study. Ophthalmology 104 (1997) 581-588
18. Kanthan G.L., Wang J.J., Rochtchina E., et al. Ten-year incidence of age-related cataract and cataract surgery in an older Australian population: the Blue Mountains Eye Study. Ophthalmology 115 (2007) 808-814
19. Hosmer D.W., and Lemeshow S. Applied Logistic Regression (1989), Wiley, New York 238-245 Wiley Series in Probability and Mathematical Statistics. Applied Probability and Statistics
20. Botto L.D., and Khoury M.J. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 153 (2001) 1016-1020
21. Cumming R.G., Mitchell P., and Leeder S.R. Inhaled corticosteroids and the risk of cataracts [letter]. N Engl J Med 337 (1997) 1555
22. Cumming R.G., and Mitchell P. Inhaled corticosteroids and cataract: prevalence, prevention and management. Drug Saf 20 (1999) 77-84
23. Lipworth B.J., and Wilson A.M. Dose response to inhaled corticosteroids: benefits and risks. Semin Respir Crit Care Med 19 (1998) 625-646
24. Urban Jr. R.C., and Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol 31 (1986) 102-110
25. James E.R. The etiology of steroid cataract. J Ocul Pharmacol Ther 23 (2007) 403-420
26. James E.R., Fresco V.M., and Robertson L.L. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J Ocul Pharmacol Ther 21 (2005) 11-27
27. James E.R., Robertson L., Ehlert E., et al. Presence of a transcriptionally active glucocorticoid receptor alpha in lens epithelial cells. Invest Ophthalmol Vis Sci 44 (2003) 5269-5276
28. Hoenders H.J., and Bloemendal H. Lens proteins and aging. J Gerontol 38 (1983) 278-286
29. Wilt T.J., Niewoehner D., MacDonald R., and Kane R.L. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med 147 (2007) 639-653
30. Denlinger L.C., Sorkness C.A., Chinchilli V.M., and Lemanske Jr. R.F. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol 119 (2007) 3-11
31. Suissa S., Baltzan M., Kremer R., and Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169 (2004) 83-88
32. Salmun L.M., Barlan I., Wolf H.M., et al. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 103 (1999) 810-815
33. Nelson H.S. Prospects for antihistamines in the treatment of asthma. J Allergy Clin Immunol 112 suppl (2003) S96-S100
34. Wen M.C., Wei C.H., Hu Z.Q., et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol 116 (2005) 517-524